While annual sales of statin drugs have reached 29-billion dollars a year, globally, new concerns are being raised by a broad range of health and consumer advocacy organizations around the world regarding the growing body of clinical research indicating they may be causing far greater harm than good.

Despite the success of statin drugs for lowering cholesterol, over 300 health problems have been linked to this chemical class of drugs in peer-reviewed clinical research found on the National Library of Medicine.